Actualización del tratamiento de las infecciones de vías urinarias en gestantes.

Abstract

Urinary tract infection is one of the main pathologies that affect normal development during the gestation period; it occurs in up to 50% of women during life. However, in pregnant women it persists in 22.7% due to changes in their function and anatomy which cause serious alterations due to not evaluating or initiating treatment. Complications that can be prevented by starting pharmacological measures must be considered to avoid irreversible damage such as threat of preterm birth, increased incidence of preterm birth with low birth weight. Objective: Identify the treatment of urinary tract infection in pregnant women. Methodology: Descriptive category study, of qualitative nature where the search for scientific articles of great impact in the medical area is carried out through the use of Medical Subject Headings (MESH), the terminology was chosen, and the search in journals such as PUBMED, ELSEVIER , Taylos&Francis or in search engines of academic prestige with the intention of increasing knowledge about the subject matter. Conclusion: In the treatment of the urinary tract according to the guidelines, urine culture should be assessed as an adequate diagnosis, which shows sensitivity and specificity, so that antibiotic prescription thus avoids bacterial resistance. Management is individualized with respect to the trimester in which the pregnant patient is studying. Treatment of asymptomatic bacteriuria is with nitrofurantoin, cephalexin, amoxicillin, amoxicillin/clavulanic acid, cystitis with fosfomycin, nitrofurantoin, amoxicillin/clavulanic acid, cefuroxime, and pyelonephritis with ceftriaxone, cefazolin, and cephalexin.